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Morphological and functional polarization of neurons depends on the generation and
maintenance of the axon initial segment (AIS). This axonal domain maintains axonal
properties but is also the place where the action potential (AP) is generated. All these
functions require the AIS, a complex structure that is not fully understood. An integrated
structure of voltage-gated ion channels, specific cytoskeleton architecture, as well as,
scaffold proteins contributes to these functions. Among them, ankyrinG plays a crucial
role to maintain ion channels and membrane proteins. However, it is still elusive how
the AIS performs its complex structural and functional regulation. Recent studies reveal
that AIS is dynamically regulated in molecular composition, length and location in
response to neuronal activity. Some mechanisms acting on AIS plasticity have been
uncovered recently, including Ca2+, calpain or calmodulin-mediated modulation, as
well as post-translational modifications of cytoskeleton proteins and actin-associated
proteins. Neurons are able to respond to different kind of physiological and pathological
stimuli from development to maturity by adapting their AIS composition, position and
length. This raises the question of which are the neuronal receptors that contribute to
the modulation of AIS plasticity. Previous studies have shown that purinergic receptor
P2X7 activation is detrimental to AIS maintenance. During initial axonal elongation,
P2X7 is coordinated with P2Y1, another purinergic receptor that is essential for proper
axon elongation. In this study, we focus on the role of P2Y1 receptor on AIS development
and maintenance. Our results show that P2Y1 receptor activity and expression are
necessary during AIS initial development, while has no role once AIS maturity is achieved.
P2Y1 inhibition or suppression results in a decrease in ankyrinG, βIV-spectrin and
voltage-gated sodium channels accumulation that can be rescued by actin stabilization
or the modulation of actin-binding proteins at the AIS. Moreover, P2X7 or calpain
inhibition also rescues ankyrinG decrease. Hence, a dynamic balance of P2Y1 and
P2X7 receptors expression and function during AIS assembly and maturation may
represent a fine regulatory mechanism in response to physiological or pathological
extracellular purines concentration.
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INTRODUCTION
The axon initial segment (AIS) plays a crucial role in neuronal
physiology, being responsible for the coordination of the whole
set of inputs that a neuron receives. This unique axonal
domain generates the action potential (AP; Stuart et al., 1997;
Kole et al., 2008) and has a high degree of plasticity that
allows the control of AP amplitude and frequency. In fact,
the AIS may undergo lengthening or shortening, changes in
its composition and can move away from soma to control
AP response (Grubb and Burrone, 2010; Kuba et al., 2010,
2015; Del Puerto et al., 2015). Further, axonal identity and
neuronal polarity depend on AIS integrity (Schafer et al., 2009).
Different mental disorders (e.g., bipolar disorder, schizophrenia)
and genetic diseases (e.g., Angelman syndrome) are related to
AIS alterations (Kaphzan et al., 2011; van der Werf et al.,
2017; Zhu et al., 2017), as well as neurodegeneration related
diseases, such as stroke, brain injury or Alzheimer’s disease
(Schafer et al., 2009; Sun et al., 2014; Del Puerto et al., 2015).
Despite the importance of AIS, our knowledge is far from
a complete understanding of its whole composition, structure
and plasticity. In this sense, it remains mostly unknown
which receptors and extracellular factors participate on AIS
development, maintenance and modulation.
The AIS comprises around the first 20–60 microns of the
axon, depending on the type of neuron and developmental stage
(for a review see Leterrier, 2018). It is composed by a high
density of voltage-gated sodium, potassium and calcium ion
channels, and also contains among others, GABA, dopamine
and serotonin receptors, which contribute to modulate APs
(Rasband, 2010). These voltage-gated ion channels are anchored
through interactions with AIS enriched scaffold proteins, such
as AnkyrinG or PSD-93 (Garrido et al., 2003; Pan et al., 2006;
Ogawa et al., 2008). AnkyrinG is the most important structural
protein in the AIS and AnkyrinG suppression drives to the
loss of polarity and axonal identity. Scaffold proteins also serve
to anchor other membrane proteins, such as L1, neurofascin
or ADAM-22 (Jenkins and Bennett, 2001; Ogawa et al., 2010).
Other extracellular proteins, such as Lgi1 (Seagar et al., 2017)
or brevican (Hedstrom et al., 2007) also contribute to this dense
protein structure. This functional and structural membrane and
submembranous scaffold are anchored to a complex cytoskeleton
by βIV-spectrin (Komada and Soriano, 2002), which interacts
with the actin cytoskeleton (Rasband, 2010). Although recent
studies have contributed to a better knowledge of this actin
cytoskeleton, whose roles in AIS maintenance, development and
function are not well understood. The AIS contains regular
actin rings and actin patches (Watanabe et al., 2012; Leterrier
et al., 2015). Some AIS actin-interacting proteins are α-actinin-
2 (Sánchez-Ponce et al., 2012), synaptopodin (Bas Orth et al.,
2007) or myosins (Evans et al., 2017; Janssen et al., 2017).
Also, the AIS contains a synaptopodin and actin-associated
structure, the cisternal organelle (Benedeczky et al., 1994),
which function is still elusive despite, changes in cisternal
organelle structure occurs during development and AIS plasticity
(Schlüter et al., 2017). Finally, a differential microtubules
cytoskeleton supports this whole structure and contributes
to axonal trafficking. This microtubules cytoskeleton contains
acetylated and detyrosinated tubulin that confers a higher degree
of stability to this cytoskeleton (Konishi and Setou, 2009;
Tapia et al., 2010).
While our knowledge of this complex interplay between
important structural and functional proteins of the AIS
increases, we still have little information about the external
regulatorymechanismsmodulating the AIS and its structural and
composition plasticity.
Recent studies have highlighted the role of some receptors
at the AIS and outside the AIS on the control of AIS
composition, integrity and structural plasticity. The function
and plasticity of AIS seem to depend on the excitatory or
inhibitory profile of hippocampal neurons, as well as the input
they receive and their developmental stage (Grubb et al., 2011).
However, the extracellular factors, receptors, and mechanisms
controlling these adaptive modifications are unknown. This
raises the question of what factors contribute to a physiological
development and maintenance of the AIS. Recent results show
that neurotransmitter receptors participate in AIS regulation.
Dopamine, through D3R receptors, modulates T-type Ca2+
channels at the AIS contributing to neuronal output (Bender
et al., 2010; Clarkson et al., 2017). Serotonin receptors (5-HT1A)
also contribute to the control of AP threshold by modulating
AIS cyclic-nucleotide-gated channels (HCN1) in the medial
superior olive (Ko et al., 2016). In addition, 5-HT1A receptors
modulate Nav1.2 voltage-gated sodium channels in the AIS of
cortical neurons, decreasing the success rate of AP generation
(Yin et al., 2017). Cannabinoid receptor 1 (CB1R) is necessary
to achieve a proper ankyrinG clustering at the AIS in the
early developmental stages of AIS (Tapia et al., 2017). Other
neurotransmitters such as ATP, through the purinergic receptor
P2X7, modulate AIS composition (Del Puerto et al., 2015).
Purinergic receptors are a wide family of receptors expressed
in neurons and glial cells and are important regulators of
neuronal excitability. They can be divided into three subfamilies,
adenosine, P2X and P2Y receptors, all activated by different
neuronal and glial secreted purines (Del Puerto et al., 2013).
They have an important role not only in physiological but also
in pathological processes (Burnstock, 2017). Among them, the
ionotropic P2X7 receptors are activated by high concentrations
of extracellular ATP, while the metabotropic P2Y1 receptor is
preferentially activated by ADP (Burnstock, 2007). P2X7 and
P2Y1 purinergic receptors have an antagonistic role and are
coordinated during initial axon elongation (del Puerto et al.,
2012). While P2X7 has a detrimental effect on axonal elongation,
P2Y1 promotes axonal elongation during the first stages of
axonal growth. These antagonistic actions are regulated by
P2X7-mediated calcium entry that inhibits adenylate cyclase
5 (AC5), and P2Y1-mediated Gq-PKCζ activation of AC5.
This generates a balance that controls cAMP production and
modulates PI3K-Akt-GSK3 pathway activity. Our previous work
demonstrated that P2X7 activation is detrimental for ankyrinG
and voltage-gated sodium channels accumulation in AIS of
mature neurons (Del Puerto et al., 2015). However, P2Y1 role
on AIS regulation has not been studied. The objective of our
study was to investigate whether P2Y1 purinergic receptor
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participates on AIS development or modulation. Our results
show that P2Y1 activity is necessary for initial AIS development
and ankyrinG accumulation while having no significant role in
mature neuron AIS. Decreased ankyrinG accumulation due to
P2Y1 suppression can be prevented through P2X7 or calpain
inhibition, revealing the crosstalk of P2Y1 and P2X7 during
AIS development. Further, P2Y1 suppression alters F-actin
distribution in AIS and decreases phosphorylation of myosin
light chain (pMLC) and ankyrinG which can be prevented by
F-actin stabilizing agent Jasplakinolide or protein phosphatase
1 and 2A inhibitor Calyculin A. Together with previous results
on purinergic regulation (del Puerto et al., 2012; Del Puerto et al.,
2015), our results suggest a necessary role for P2Y1 for the early
development of the AIS. However, with neuronal maturation, the
importance of P2Y1 decreases while P2X7 gains and increasing
relevance in AIS maintenance and modulation.
MATERIALS AND METHODS
Reagents and Plasmids
Reagents were obtained from the following manufacturers:
Adenosine 5’-diphosphate sodium ADP (A2754),
P2X7 antagonist, BBG (B0770), AC5 inhibitor, NKY80
(N2165) and PP1/PP2A phosphatases inhibitor calyculin A
(C5552) were obtained from Sigma-Aldrich. P2Y Antagonist
II (BPTU; 504187) was obtained from EMD Millipore.
2-Methylthioadenosine diphosphate trisodium salt (2-MeSADP;
1624), (N)-methanocarba-2MeSADP (MRS 2365; 2157), the
calpain inhibitor MDL 28170 and jasplakinolide were obtained
from Tocris. P2Y1 shRNA and scrambled shRNA plasmids have
been previously published and validated (del Puerto et al., 2012).
Animals
Animals were housed in a room at controlled temperature
and relative humidity with alternating 12 h light and dark
cycles and free access to food and water ‘‘ad libitum.’’ Animal
care protocols used in our laboratory are in conformity with
the appropriate national legislation (53/2013, BOE no. 1337)
and guidelines of the Council of the European Communities
(2010/63/UE). All protocols were previously approved by the
CSIC bioethics committee.
Neuronal Culture
Mouse hippocampal neurons were prepared as previously
described (del Puerto et al., 2012; Del Puerto et al., 2015).
Neurons were obtained from E17 mouse hippocampi, which
were incubated in a 0.25% trypsin solution in Ca2+/Mg2+
free Hank’s buffered salt solution (HBSS) and dissociated
using fire-polished Pasteur pipettes. The cells were plated
on polylysine-coated coverslips (1 mg/ml) at a density of
5,000 cells/cm2 for 2 h in plating medium [minimum
essential medium (MEM), 10% horse serum, 0.6% glucose and
Glutamax-I]. Then coverslips were inverted and transferred to
culture dishes containing astrocytes. Astrocytes medium was
replaced by neuronal culture medium 24 h before neuronal
culture (Neurobasal medium, B27 supplement, Glutamax-I).
To avoid contact between neurons and astrocytes, paraffin
beads were placed on coverslips before neuronal plating. Five
micromolar 1-β-D-arabinofuranosylcytosine (AraC) was added
after 2 days in culture to avoid glial cells proliferation. One-third
of neuronal medium was replaced every week. Pharmacological
treatments were applied as described in the ‘‘Results’’ section.
In the case of pharmacological treatments in the absence of
glial cell layer, coverslips were transferred to plates containing
glial cells-conditioned medium. Primary hippocampal neurons
were nucleofected using the Amaxa nucleofector kit for primary
mammalian neural cells (Amaxa Bioscience) according to the
manufacturer’s instructions. Nucleofection was performed using
3 µg of total DNA and 3 × 106 cells for each nucleofection.
Neurons were plated at a density of 10,000 cells/cm2 as described
above. Nucleofection efficiency was ∼15% of neurons, based on
the number of GFP-positive neurons. For lipofection, neurons
were plated at a density of 20,000 cells/cm2 and transfected at
7 or 10 DIV. Lipofection was performed using Lipofectamine
2000 (Life Technologies) and 3 µg of total DNA following
manufacturer instructions.
Immunofluorescence
Neurons from each experiment, containing all experimental
conditions to be compared, were fixed in 4% PFA. To standardize
staining, all these coverslips were treated at the same time
for immunofluorescence following the same conditions. Briefly,
coverslips were treated for 10 min with 50 mM NH4Cl and
incubated in blocking buffer (0.22% gelatine, 0.1% Triton X-100
in PBS) for 30 min, before incubation with primary antibodies
for 1 h at room temperature in blocking buffer. The primary
antibodies used were: chicken anti-MAP2 (1:10,000, Abcam,
ab5392), mouse anti-ankyrinG (1:100) from NeuroMab (clone
N106/36), mouse anti-pan sodium channel (1:100) from Sigma
(clone K58/35), rabbit anti-pMLC (1:200) from Thermo Fisher
(PA5-17727) and rabbit βIV-spectrin (1:1,000; a gift from Dr.
M. Rasband, Baylor College of Medicine, Houston, TX, USA).
The secondary antibodies used were a goat or donkey anti-
mouse, anti-rabbit or anti-chicken Alexa-Fluor 488, 594, or 647
(1:1,000). Phalloidin Alexa-Fluor 594 was used at a concentration
of 1:100. Images from each immunofluorescence were acquired
on a Leica SP5 confocal microscope maintaining the same
acquisition parameters to compare intensities. Figures were
prepared for presentation using the Adobe CS4 software.
Dendrites and AIS Measurements
Quantification of fluorescence intensity at the AIS was performed
on confocal images of neurons from at least three independent
experiments. Neurons were randomly acquired without any bias
by scanning each coverslip from top to bottom. All confocal
images within the same experiment and immunofluorescence
were acquired using exactly the same parameters of laser
intensity, excitation and emission detection during the same
working session for each Alexa fluorophore. Parameters were set
in control neurons and maintained for the other experimental
groups. After completing images acquisition of all conditions,
ankyrinG and other AIS proteins staining were quantified using
ImageJ software. We drew a line starting at the limit of neuronal
soma identified by MAP2 staining and extended it along the
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ankyrinG staining or the GFP signal of the axon. Data from every
0.16µmalong the first 40µmwere obtained and smoothed using
the Sigmaplot software to obtain average ankyrinG fluorescence
intensity every 1 µm. Data were normalized in each neuron,
within the same immunofluorescence, considering the value of
maximum mean fluorescence in control neurons to be 100%.
Total fluorescence intensity for each neuron was obtained by
adding ankyrinG fluorescence values from 0 to 40 µm. In
some experiments, the total ankyrinG intensity was calculated
within each AIS length and data normalized to AIS length
of each neuron. AIS start, end and maximum fluorescence
intensity were determined following the criteria described in
Grubb and Burrone (2010). Taking 100% fluorescence as the
maximum fluorescence intensity point, start and end points
were defined as the points were fluorescence intensity is lower
than 33%. For actin patches quantification, neurons were stained
with Phalloidin-Alexa 594 (1:100) and ankyrinG to detect
the AIS. Puncta of relatively uniform diameter of less than
3 µm within AIS were considered to be patches (Balasanyan
et al., 2017). To avoid any possible loss of actin patches by
lower F-actin intensity, image intensity was increased for the
purpose of identification and quantification of all possible
actin patches.
Dendrites lengths were obtained based on MAP2 staining
using NeuronJ software to measure the length of the dendritic
arbor in each neuron. All dendrites and ramifications in each
neuron were traced using NeuronJ and their total length added.
GFP signal of neurons under analysis allowed discriminating
from crossing dendrites from other neurons. In order to study
correlations between dendrites and AIS fluorescence, both data
were obtained from the same neurons.
Statistical Analysis
All statistical analyses were carried out in Sigmaplot v12.5 (Systat
Software Inc.) and Prism 5 (GraphPad Software, Inc., La Jolla,
CA, USA). Data for each independent sample were obtained from
at least three independent experiments. For pharmacological
experiments, data from each experiment were collected from at
least 30 cells (between 30 and 50 cells) in each experimental
condition. For nucleofection or lipofection experiments around
25 neurons from each experiment in each experimental condition
were analyzed. Statistical analysis was performed by t-test for
two group comparisons and one-way ANOVA for multiple
group comparisons. When data were non-normally distributed,
non-parametric tests were used: Mann-Whitney Rank test for
two independent samples and Kruskal-Wallis for analysis of
multiple groups. In the analysis of multiple comparisons, a
post hoc analysis was performed using Dunn’s test. All p-values
were adjusted to account for multiple comparisons. Cell-to-
cell analysis of dendrite length and ankyrinG fluorescence was
performed using Prism 5 and Sigmaplot v12.5. First, we tested
the normality of data distribution on each variable using a
Shapiro-Wilk or Kolmogorov-Smirnov normality test. As not all
data passed normality test, the correlation was analyzed using the
Pearson correlation function or Spearman correlation function
when data failed normality test. Differences were considered
significant when p< 0.05.
RESULTS
ADP Activation of P2Y1 Increases
AnkyrinG Levels in the Developing Axon
Initial Segments
A previous study demonstrated that the AIS of mature
cultured hippocampal neurons (21 DIV) is regulated by
ATP and P2X7 receptor (Del Puerto et al., 2015). Due
to the coordinated action of ATP and ADP during initial
axon elongation, we have investigated whether ADP and
P2Y1 play a role in AIS regulation. Hippocampal neurons
were treated with vehicle or ADP 10 µM during the 3 days
prior fixation at 10, 14 or 21 DIV. AnkyrinG levels were
then analyzed after immunofluorescence (Figures 1A–D). ADP
treatment increased ankyrinG fluorescence intensity at the
AIS in neurons treated from 7 to 10 DIV (146.74 ± 2.48%)
compared to 10 DIV control neurons (100 ± 1.76%). However,
ADP treatment in 14 DIV neurons had no significant
effect in ankyrinG levels (113.74 ± 3.81%) vs. 14 DIV
control neurons (100 ± 3.78%), as also happened for ADP
treatment in 21 DIV neurons (110.38 ± 3.89% vs. AIS
of 10 and 21 DIV neurons (Figures 1B,C). Next, we
treated neurons with two more P2Y1 agonists, 2MeSADP
(10 µM) and MRS-2365 (10 µM). Both agonists also increased
significantly ankyrinG intensity at the AIS of 7–10 DIV
treated neurons (Figures 1E,F), suggesting a P2Y1 mediated
effect of ADP.
P2Y1 Receptor Suppression or Inhibition
Decreases AnkyrinG Accumulation at the
AIS During Initial Developmental Stages
In order to ensure that ADP effect was due to P2Y1 receptor
activation, we nucleofected neurons before plating using
scrambled (shscr) or P2Y1 (shP2Y1) interference RNAs that
also express GFP. Neurons were left in culture for 4, 7, 14 or
21 DIV, fixed and stained with MAP2 and ankyrinG antibodies
(Figures 2A–D). P2Y1 interference RNA significantly decreased
ankyrinG intensity between 4 and 14 DIV (Figure 2E), with
the maximum reduction found at 7 DIV (77.07 ± 3.79%)
compared to 100 ± 4.75% in sh scrambled 7 DIV control
neurons. Fourteen DIV neurons recovered when compared to
7 DIV neurons (86.58 ± 2.36%), and no significant change was
observed in 21 DIV neurons. To ascertain that ADP treatment
has no effect on ankyrinG intensity after P2Y1 suppression,
nucleofected 7 DIV neurons were treated with ADP 10 µM for
3 days. Neurons nucleofected with scramble shRNA increased
ankyrinG intensity after ADP treatment, while those expressing
shP2Y1 did not respond to ADP treatment (Figure 2F). Next,
we checked whether the fluorescence intensity of ankyrinG
interacting proteins, βIV-spectrin and voltage-gated sodium
channels, was also reduced in 7 DIV neurons (Figure 2G). Both
proteins significantly decreased their expression at the AIS after
P2Y1 suppression (72.19± 5.67%, panNaCh and 70.69± 6.46%,
βIV-spectrin) and the percentage was similar to ankyrinG
(Figure 2E). To rule out the possibility that shP2Y1 efficiency was
progressively lost during in vitro development, we introduced
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FIGURE 1 | ADP and P2Y1 agonists potentiates ankyrinG expression during early axon initial segment (AIS) development. (A) Normalized ankyrinG fluorescence
intensity in 10, 14 and 21 DIV hippocampal neurons. Neurons were treated with ADP for 3 days before fixation (blue symbols). Data were acquired from three
independent experiments (30 neurons/experimental condition in each experiment). Same pool of neurons was used for each experiment and fixed at different times.
All images were acquired by confocal microscopy using the same fluorescence parameters. Statistical differences were analyzed by a Kruskal-Wallis test followed by
a Dunn’s multiple comparisons post-test. Adjusted p values: ∗∗∗p < 0.001. (B,C) Normalized AnkyrinG intensity profile along the AIS of 10 DIV (B) and 21 DIV (C)
hippocampal neurons in the presence (green line) or absence (black line) of 10 µM ADP treatments. (D) Control and ADP treated 10 DIV and 21 DIV neurons stained
with MAP2 (blue) and ankyrinG antibodies (green). Scale bar = 100 µm. Four times-magnification of the ankyrinG staining (green) at the AIS is shown below images.
(E) Normalized ankyrinG intensity at the AIS of 10 DIV neurons treated with ADP and P2Y1 agonists 2-methylthioadenosine diphosphate trisodium salt (2MeSADP) or
MRS-2365 from 7 to 10 DIV. Data were acquired from three independent experiments (30 neurons/experimental condition in each experiment). ∗∗∗p < 0.001, two-tail
t-test. (F) 10 DIV hippocampal neurons stained with MAP2 (blue) and ankyrinG antibodies (green) treated with 2MeSADP (10 µM) or MRS-2365 (10 µM). Data in
graphs are represented as the mean ± SEM.
control scrambled shRNA and P2Y1 shRNA by lipofection in
7 or 10 DIV neurons. Neurons were left 2–3 days and ankyrinG
signal was analyzed (Figure 2H). Lipofected neurons expressing
shP2Y1 did not show any reduction of ankyrinG levels at
neither 10 or 12 DIV, confirming that in cultured hippocampal
neurons P2Y1 exerts its action only during the initial steps of
AIS development. This timing correlates with the stages prior
to which the AIS diffusion barrier is developed at 10 DIV
(Brachet et al., 2010).
In view of these results, we next checked whether
P2Y1 pharmacological inhibition was enough to
reduce ankyrinG levels. For this purpose, we used the
non-nucleotide allosteric and none ADP-competitive P2Y1
antagonist, BPTU (1-(2-(2-(tert-butyl)phenoxy)pyridin-3-yl)
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FIGURE 2 | P2Y1 receptor is necessary to maintain ankyrinG density during early stages of AIS development. (A–D) 4, 7, 14 and 21 DIV hippocampal neurons
nucleofected with scrambled and P2Y1 shRNAs. After nucleofection neurons were kept in culture for 4 (A), 7 (B), 14 (C) and 21 days (D) and stained with MAP2
(blue) and ankyrinG (red) antibodies. Nucleofected neurons were identified by GFP expression (green). Inserts show magnifications of AISs (gray) of each neuron.
(E) Normalized ankyrinG intensity at different days post-nucleofection with scrambled shRNA (shscr, black) or P2Y1 shRNA (shP2Y1, red). shP2Y1 data are
normalized to their respective shscr controls at each developmental stage. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, two-tail t-test. (F) Normalized ankyrinG intensity in
10 DIV neurons expressing shscr or shP2Y1 plasmids, treated with vehicle or ADP from 7 to 10 DIV. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, two-tail t-test. Data were
acquired from three independent experiments (30 neurons/experimental condition in each experiment). (G) βIV-spectrin and voltage-gated sodium channels
(PanNaCh) normalized intensity in 7 DIV control shscr and shP2Y1 expressing neurons. ∗p < 0.05, ∗∗∗p < 0.001, two-tail t-test. Data were acquired from three
independent experiments (at least 25 neurons/experimental condition in each experiment). (H) Normalized ankyrinG intensity in 10 and 12 DIV hippocampal
transfected at 7 or 10 DIV, respectively, to express shscr or shP2Y1 interference RNAs. Data were acquired from three independent experiments (at least
20 neurons/experimental condition in each experiment). n.s., not significant, two tail t-test. Data in graphs are represented as the mean ± SEM.
-3-(4-(trifluoromethoxy)phenyl)urea; Mañé et al., 2016). First,
we determined the most efficient dose in cultured hippocampal
neurons. Seven DIV neurons were treated for 3 days with
BPTU at concentrations of 0.5, 1, 2, 5, 7, 10 and 20 nM and
ankyrinG levels were evaluated (Figure 3A). AnkyrinG levels
decreased linearly with increasing BPTU concentration. BPTU
doses under 10 nM did not affect neuronal viability, but
concentrations higher than 10 nM had a detrimental effect
on neuronal survival due to alterations on glial cell layer
morphology and viability (data not shown). Consequently,
we decided to inhibit P2Y1 using 5 nM BPTU treatments
in 7 DIV neurons for 3 days (Figure 3C). While 7–10 DIV
neurons increased ankyrinG levels after ADP treatment, 5 nM
BPTU reduced ankyrinG levels (Figure 3B) to similar levels
(75.21 ± 1.54%) than those observed in shP2Y1 neurons
(77.07 ± 3.79%, Figure 2E, or 63.86 ± 4.95%, Figure 3E). No
difference was observed between the ADP and BPTU vehicles,
water and DMSO, respectively (Figure 3B). Moreover, BPTU
treatment impaired the positive effect of ADP on ankyrinG
(Figure 3D). Finally, we combined shP2Y1 with BPTU and again
assessed ankyrinG. 10 DIV neurons expressing shP2Y1 had
decreased ankyrinG expression (63.86 ± 4.95%), which was
significantly reduced (49.38 ± 2.76%) by BPTU treatment in
shP2Y1 neurons (Figure 3E). The fact that BPTU has an additive
effect with P2Y1 suppression may be explained by the fact that
still some P2Y1 receptors are available and BPTU is a potent
P2Y1 inhibitor. shP2Y1 has an efficiency of 70% reducing
P2Y1 expression in cell lines (del Puerto et al., 2012). On the
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FIGURE 3 | P2Y1 pharmacological inhibition decreases ankyrinG accumulation at the AIS. (A) Normalized ankyrinG intensity on 10 DIV hippocampal neurons
treated from 7 DIV with increasing concentrations of the P2Y1 antagonist, BPTU (0.5, 1, 2, 5, 7 and 10 nM). Concentrations higher than 10 nM affected the
morphology of supporting glial cells and were discarded to avoid secondary effects on neurons. (B) AnkyrinG intensity profile along the AIS of hippocampal neurons
treated from 7 to 10 DIV with vehicle black line), DMSO (BPTU vehicle, gray line), ADP (green line) and BPTU (red line). (C) 10 DIV neurons stained with MAP2 (blue)
and ankyrinG antibodies (green) and treated with vehicle (control) or 5 nM BPTU from 7 to 10 DIV. Inserts show a magnification of the respective AIS. (D) Normalized
ankyrinG intensity on 10 DIV hippocampal neurons treated from 7 DIV with 10 µM ADP and BPTU 5 nM, alone or in combination. (E) Normalized ankyrinG intensity
on 10 DIV shscr or shP2Y1 nucleofected hippocampal neurons treated with BPTU from 7 DIV. Data were acquired from three independent experiments (at least
30 neurons/experimental condition in each experiment). ∗∗p < 0.01, ∗∗∗p < 0.001, n.s. not significant, two-tail t-test. Data in graphs are represented as the
mean ± SEM.
other hand, it is the first time that BPTU is used in neurons. We
can not discard that BPTU is partially affecting other purinergic
receptors. However, BPTU impairs ADP-mediated increase
of ankyrinG fluorescence. Therefore, our results suggest that
P2Y1 activation is necessary to maintain ankyrinG levels at
the AIS during the first stages of AIS development. This led
to the question which are the mechanisms or developmental
events that are under P2Y1 regulation that contribute to AIS
proteins accumulation.
AnkyrinG and Dendrites or AIS Length do
Not Correlate in Neurons Lacking
P2Y1 Receptor
P2Y1 receptor is not detected at the AIS but is located in
dendrites, distal axon and presynaptic terminals in cultured
hippocampal neurons (del Puerto et al., 2012). We recently
demonstrated that ankyrinG decrease at AIS was correlated
with impaired dendrite development mediated by CB1R
inhibition (Tapia et al., 2017) and previous studies demonstrated
that P2Y1 modulate neuronal morphology during the initial
stages of development (del Puerto et al., 2012). Dendrites
start their development in cultured hippocampal neurons
at 4 DIV (Dotti et al., 1988). In order to test whether
P2Y1 may control dendrite development and also influence
AIS development, we measured the cell-to-cell dendritic
length and ankyrinG fluorescence intensity in 7 DIV shscr
and shP2Y1 nucleofected neurons (Figures 4A,B). As
happened when CB1 expression was reduced (Tapia et al.,
2017), dendrites of 7 DIV shP2Y1 neurons were shorter
(320.2 ± 14.1 µm) than in control neurons (397.1 ± 20.37 µm,
Figures 4C,E). Moreover, ankyrinG expression at the AIS
was also reduced by 20% (Figures 4D,E). Even though
a similar percentage reduction of dendrites length and
ankyrinG was observed (Figure 4E), we analyzed both
parameters in each individual neuron (Figure 4F). While
we found a significant correlation between dendritic arbor
length and ankyrinG expression in sh scrambled control
neurons (Spearman r = 0.3037, p = 0.0055), there was
no significant correlation in shP2Y1 neurons (Spearman
r =−0.1522, p = 0.1955).
On the other hand, the AIS is known to respond to
stimulus or absence of stimulus with plasticity mechanisms
that include changes in composition, length and position
(Grubb and Burrone, 2010; Kuba et al., 2010; Del Puerto
et al., 2015). Therefore, we analyzed AIS length in 7 and
14 DIV shscr and shP2Y1 neurons (Figure 5). No significant
AIS length differences were found in 7 DIV shP2Y1 neurons
(26.06 ± 1.03 µm) compared to control 7 DIV sh scrambled
neurons (23.52 ± 0.97 µm), neither in AIS position or
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FIGURE 4 | No correlation between P2Y1 suppression-mediated decrease of dendrites length and ankyrinG density. (A,B) Representative images of 7 DIV
hippocampal neurons nucleofected with scrambled or P2Y1 shRNAs. After nucleofection neurons were kept in culture for 7 DIV and stained with MAP2 (blue) and
ankyrinG (red) antibodies. Nucleofected neurons were identified by GFP expression (green). (C,D) Box-plots represent total dendritic length (C) and ankyrinG
intensity (D) of 7 DIV scrambled sh (sh scr) or shP2Y1 nuclefected neurons from the same pools in three different experiments. Line inside the box represents the
median, and upper and bottom lines represent the maximum and minimum values. ∗∗p < 0.01, ∗∗∗p < 0.001, two-tail t-test. (E) Normalized mean ± SEM of
dendrites length and ankyrinG intensity of data represented in (C,D). (F) Correlation graph of dendrites length and ankyrinG intensity for each individual neuron
analyzed in the study. Control neurons (shscr) are represented in black and neurons expressing P2Y1 interference RNA (shP2Y1) are in red. Data were analyzed first
with two normality tests (Shapiro-Wilk and Kolmogorov-Smirnov). Not all data sets did fit a normal distribution and a non-parametric correlation test (Spearman) was
performed. Regression lines are shown for shscr (black) and shP2Y1 (red) neurons. The number of neurons, Spearman r coefficient and p values are indicated in (F).
A positive correlation is observed in control neurons, while there is no significant correlation in neurons expressing shP2Y1 interference RNA.
maximum ankyrinG intensity position (Figures 5A,B). No
significant change in AIS length was also obtained in 14 DIV
neurons, being AIS length around 33 µm in sh scrambled and
shP2Y1 neurons (Figure 5E). However, in 14 DIV neurons,
P2Y1 suppression generated a significant proximal shift of
ankyrinG maximum intensity of 2–3 µm (7.37 ± 0.41 µm vs.
9.58 ± 0.53 µm in sh scrambled neurons, Figure 5I), which
can be observed in the mean profile of ankyrinG expression
along the AIS (Figure 5J). Despite no AIS length mean changes
were observed between scrambled sh and shP2Y1 neurons,
there is variability of AIS length within each experimental
group. Thus, we analyzed ankyrinG intensity within the AIS
length of each neuron (Figures 5C,F). Our results show a
significant reduction of the mean ratio ankyrinG/AIS length
in shP2Y1 neurons at 7 DIV (around 30%, Figure 5D) and
14 DIV (around 10%, Figure 5G). Furthermore, we analyzed
whether AIS length and ankyrinG intensity are correlated in
14 DIV scrambled sh and shP2Y1 neurons (Figure 5H). Both
parameters were significantly correlated in control scrambled
sh neurons, while no significant correlation was found
in shP2Y1 neurons, demonstrating that ankyrinG intensity
reduction in shP2Y1 neurons is not related to changes in AIS
length. This data suggest that besides neuronal morphology
regulation, P2Y1 receptor maintain other mechanisms to
regulate AIS development.
P2X7 Inhibition Recovers AnkyrinG
Expression
Our previous results showed that P2Y1 suppression produced
a shorter axon, which was recovered by P2X7 inhibition with
BBG (del Puerto et al., 2012). P2Y1-Gq and P2X7-mediated
calcium entry are coordinated through AC5 activation
(P2Y1) or inhibition (P2X7). This generates a cAMP balance
that modulates the PI3K/Akt/GSK3 pathway. In addition,
P2X7 modulate ankyrinG expression at the AIS through a
calcium-calpain-dependent mechanism (Del Puerto et al., 2015).
In order to test whether the same coordinated pathway is
also related to AIS modulation, we treated neurons from 7 to
10 DIV with the adenylate cyclase inhibitor NKY80 (10 µM)
and analyzed ankyrinG (Figure 6A). NKY80 significantly
reduced ankyrinG expression by around 10%, suggesting
a coordinated action of P2Y1 and P2X7. Next, 6 DIV
sh scrambled and shP2Y1 neurons were treated for 24 h
with BBG (100 nM), a well-characterized P2X7 inhibitor
(Figures 6B,D). P2X7 inhibition resulted in a non-significant
trend to increase ankyrinG fluorescence in sh scrambled neurons
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FIGURE 5 | No correlation between P2Y1 suppression-mediated decrease of ankyrinG density and AIS length. (A) Graph represents AIS length of each 7 DIV
neuron nucleofected with scrambled sh (black dots) or shP2Y1 (red dots). Lines represent the mean ± SEM. (B) Graph represents the mean ± SEM of AIS start
point, maximum intensity point and end point of AIS in 7 DIV scrambled shRNA or P2Y1 shRNA nucleofected neurons. (C) Normalized ankyrinG intensity within the
respective AIS length of neurons represented in (A). (D) Normalized AnkyrinG/AIS length ratio for each 7 DIV scrambled shRNA or P2Y1 shRNA nucleofected
neuron. (E) Graph represents AIS length of each 14 DIV neuron nucleofected with scrambled sh (black dots) or shP2Y1 (red dots). Lines represent the mean ± SEM.
(F) Normalized ankyrinG intensity within the respective AIS length of neurons represented in (E). Adjacent graph represents the mean ± SEM. (G) Normalized
AnkyrinG/AIS length ratio for each 14 DIV scrambled shRNA or P2Y1 shRNA nucleofected neuron. Adjacent graph represents the mean ± SEM. (H) Correlation
graph of AIS length and ankyrinG intensity for each individual 14 DIV neuron nucleofected with scrambled (black dots) or P2Y1 (red dots) shRNAs. Values are the
same represented in (E,F). Data were analyzed first with two normality tests (Shapiro-Wilk and Kolmogorov-Smirnov). All data sets did fit a normal distribution and a
Pearson correlation test was used. Regression lines are shown for shscr (black) and shP2Y1 (red) neurons. The number of neurons, Pearson r coefficient and p
values are indicated in (H). A positive correlation is observed in control neurons, while there is no significant correlation in neurons expressing shP2Y1 interference
RNA. (I) Graph represents the mean ± SEM of AIS start point, maximum intensity point and end point of AIS in 14 DIV scrambled shRNA or P2Y1 shRNA
nucleofected neurons. Note a significant proximal shift of the maximum intensity point. (J) AnkyrinG profile along AIS length of 14 DIV neurons, indicating the
proximal shift of the maximum ankyrinG intensity. Data are represented as the mean ± SEM of ankyrinG intensity every 1 micron. ∗p < 0.05, ∗∗p < 0.01,
∗∗∗p < 0.001, n.s., non-significant.
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FIGURE 6 | P2X7 inhibition recovers ankyrinG density in shP2Y1 nucleofected neurons. (A) Scatter plot showing normalized ankyrinG intensity in 10 DIV control
neurons or treated with the adenylate cyclase 5 (AC5) inhibitor NKY80 (10 µM) from 7 to 10 DIV. Mean ± SEM for each condition is shown in the adjacent graph.
∗∗∗p < 0.001, n.s. no significant, two-tail t-test. (B) Scatter plot of normalized ankyrinG intensity in 7 DIV transfected with scrambled shRNA or P2Y1 shRNA and
treated with the P2X7 antagonist, BBG (100 nM) from 6 to 7 DIV. Mean ± SEM for each condition is shown in the adjacent graph. Statistical differences were
analyzed by a Kruskal-Wallis test followed by a Dunn’s multiple comparisons post-test. ∗p < 0.05, ∗∗∗p < 0.001, n.s., non-significant. (C) Mean ± SEM of normalized
ankyrinG intensity in 7 DIV nucleofected with scrambled shRNA or P2Y1 shRNA and treated with the calpain inhibitor, MDL-28170 (50 nM) from 6 to 7 DIV. Statistical
differences were analyzed by a Kruskal-Wallis test followed by a Dunn’s multiple comparisons post-test. ∗p < 0.05, ∗∗∗p < 0.001, n.s., non-significant. (D)
Representative images of scrambled shRNA or P2Y1 shRNA treated with the P2X7 antagonist, BBG (100 nM). Neurons were stained with MAP2 (blue) and ankyrinG
(red) antibodies. Nucleofected neurons were identified by GFP signal (green). Axon initials segments were magnified and presented in panels below.
(105.0 ± 4.59%), while P2Y1 suppression (shP2Y1 neurons)
reduced ankyrinG fluoresecence around 25% (74.13 ± 3.98%).
Interestingly, 24 h inhibition of P2X7 recovered ankyrinG
intensity to control levels (92.7 ± 4.71%, Figures 6B,D).
Further, 24 h treatment with the calpain inhibitor MDL-28170
(50 nM) recovered ankyrinG fluorescence (95.1 ± 4.49%) in
shP2Y1 neurons (Figure 6C). This data suggests a coordinated
and antagonistic action of P2Y1 and P2X7 receptors during
initial stages of AIS development, which may depend on
the amount of ATP and ADP in extracellular medium and
their expression levels during AIS development. However,
P2X7 inhibition did not completely recover ankyrinG
intensity as previously observed in mature neurons (Del
Puerto et al., 2015), suggesting that P2X7 participation
is limited in young neurons. Thus, other AIS intrinsic
mechanisms may be regulated by P2Y1 in AIS initial
developmental stages.
P2Y1 Suppression Modifies AIS Actin
Cytoskeleton and Myosin II Light Chain
Phosphorylation
Recently, actin dynamics at the AIS were related to AIS
plasticity (Berger et al., 2018). Activity-dependent AIS plasticity
can produce a dramatic reorganization of the actin periodic
structure (Berger et al., 2018) and P2Y1 signaling pathways
can activate the RhoGTPase Rac, which modulates actin
dynamics in migration and differentiation processes (Soulet
et al., 2005). To understand whether our results can be
attributable to actin cytoskeleton modifications mediated by
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FIGURE 7 | P2Y1 suppression alters AIS F-actin. (A,B) Representative images of 7 DIV neurons nucleofected with scrambled (A) or P2Y1 (B) shRNAs. AISs were
identified by ankyrinG staining (blue) and Phalloidin-Alexa594 served to identify F-actin (red). Nucleofected neurons were identified by their GFP expression (green).
Panels show AIS region of the respective neurons and a 2.5× magnification of AIS. Gray scale images show phalloidin staining at the respective AISs. (C) Graph
represents the mean ± SEM number of actin patches identified in scrambled (black, n = 20) and shP2Y1 (red, n = 20) AISs. ∗p < 0.05, two-tail t-test. (D) Total AIS
F-actin intensity based on Phalloidin-Alexa 594 fluorescence intensity along ankyrinG signal in 7 DIV shscr and shP2Y1 neurons. ∗p < 0.05, two-tail t-test. (E) Plot
profile of F-actin intensity along AIS in 7 DIV scrambled shRNA (n = 24, black) or P2Y1 shRNA (n = 22, red) neurons. Data are represented as the mean ± SEM of
values every micron. (F) Scatter plot and mean ± SEM representing normalized ankyrinG intensity of each 7 DIV scrambled shRNA (sh scr) or P2Y1 shRNA (shP2Y1)
nucleofected neuron, treated or not with the actin stabilizer jasplakinolide (10 nM) during 4 h prior to fixation. Statistical differences were analyzed by a Kruskal-Wallis
test followed by a Dunn’s multiple comparisons post-test. ∗p < 0.05, ∗∗∗p < 0.001, n.s., non-significant.
P2Y1 receptor, we stained neurons 7 DIV scrambled sh and
shP2Y1 neurons with fluorescence phalloidin (Figures 7A,B)
and quantified F-actin intensity along the AIS, as well as
the number of actin patches (Figures 7C,D). Total F-actin
intensity was reduced by around 30% in shP2Y1 neurons
(Figure 7D), and so was ankyrinG intensity (Figure 7F).
Besides, the F-actin intensity decrease in the AIS was confirmed
by the profile (Figure 7E). While actin patches were visible
in control AISs, these were highly reduced in intensity and
visibility in shP2Y1 neurons (Figures 7A,B). Actin patches
quantification, independently of their intensity, showed that
scrambled sh neurons contained 4.8 ± 0.48 actin patches, while
shP2Y1 neurons only 3.2 ± 0.41 patches (Figure 7C). If loss of
P2Y1-dependent stabilization of the actin cytoskeleton results
in the decrease in ankyrinG, then it may be recovered by actin
stabilization. Thus, we treated scrambled and shP2Y1 neurons
with an F-actin stabilizing agent, Jasplakinolide (10 nM) for
4 h (Figure 7F). AnkyrinG expression in shP2Y1 neurons was
significantly recovered by Jasplakinolide treatment (90.6± 4.7%)
when compared to shP2Y1 neurons with no treatment
(65.27 ± 2.59%, p = 0.0002). After recovery, the level was
equivalent to sh scrambled control neurons (100 ± 4.36%).
In control sh scrambled neurons, Jasplakinolide generated a
decrease in ankyrinG expression (around 14%), which may
be due to a deregulation of actin dynamics and higher
actin stabilization.
How can actin cytoskeleton instability resulting from lack of
P2Y1 activity modify ankyrinG in the AIS? Recently published
work has highlighted the role of myosin II and myosin light
chain phosphorylation (pMLC) on AIS (Evans et al., 2017;
Berger et al., 2018). In platelets, ADP and P2Y1 activity
contribute to shape changes by increasing pMLC levels in
a calcium-calmodulin dependent manner (Paul et al., 1999).
Therefore, we analyzed pMLC levels and localization in 7 DIV
shP2Y1 neurons (Figure 8A). As previously demonstrated
(Berger et al., 2018), pMLC was localized at the AIS in
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FIGURE 8 | P2Y1 is necessary to maintain myosin light chain (MLC) phosphorylation at the AIS. (A) Representative images of 7 DIV scrambled shRNA or
P2Y1 shRNA nucleofected neurons showing phosphorylation of MLC (pMLC) staining in the AIS. Neurons were stained with MAP2 (blue) and pMLC (red) antibodies.
Nucleofected neurons were identified by GFP signal (green). pMLC staining at axon initials segments was magnified and presented in panels below (red). (B) Scatter
plot for each neuron (left) and mean ± SEM (right) representing normalized pMLC intensity at the AIS of 7 DIV neurons nucleofected with scrambled shRNA or
P2Y1 shRNA. ∗∗∗p < 0.001, two-tail t-test. (C) Scatter plot representing normalized pMLC intensity at the AIS of 7 DIV neurons nucleofected with scrambled shRNA
or P2Y1 shRNA and treated with 1 nM calyculinA (CalyA) for 3 h before fixation. Mean ± SEM of these values is represented in the adjacent graph. (D) Scatter plot
representing normalized ankyrinG intensity at the AIS of 7 DIV neurons nucleofected with scrambled shRNA or P2Y1 shRNA and treated with 1 nM calyculinA (CalyA)
for 3 h before fixation. Mean ± SEM are represented in the adjacent graph. Statistical differences in (C,D) were analyzed by a Kruskal-Wallis test followed by a
Dunn’s multiple comparisons post-test. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
7 DIV control neurons. However, pMLC staining in the
AIS was 20% lower in shP2Y1 neurons (Figure 8B). Next,
we analyzed whether treating neurons with CalyculinA to
inhibit PP1/PP2A, the phosphatases acting on pMLC, could
recover pMLC levels and, consequently, ankyrinG. Calyculin
A (1 nM) treatment for 3 h increased pMLC intensity at
the AIS of control neurons by 40%, while in non-treated
shP2Y1 neurons it was reduced by 31% (Figure 8C). Calyculin
A treatment in shP2Y1 neurons increased pMLC intensity by
25% when compared to control neurons without Calyculin A
treatment. AnkyrinG intensity analysis in the same experimental
conditions revealed a recovery of ankyrinG in shP2Y1 neurons
treated with Calyculin A (87.82 ± 4.01%) compared to
shP2Y1 neurons (72.04 ± 3.08%), which did not completely
reach reference control levels (100 ± 4.16%, Figure 8D).
Interestingly, 3 h treatment of calyculin A in control neurons
reduced ankyrinG intensity (78.5 ± 3.89%). This may suggest
that increased pMLC levels are also detrimental to ankyrinG
clustering at the AIS, as happened with F-actin stabilization with
jasplakinolide (Figure 7F).
Altogether, our results underscore the role of
P2Y1 as one of the receptors that contribute to AIS
plasticity during early events of AIS maturation. Further
investigations are required to completely understand the
signaling pathway and interactions with other receptors
and neurotransmitters.
DISCUSSION
Relevant studies have recently underscored the importance of
AIS in neurodevelopmental disorders and neurodegenerative
diseases (Kaphzan et al., 2011; Sun et al., 2014; van der Werf
et al., 2017). Changes in AIS protein composition have been
detected in models of disease, such as Angelman syndrome or
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Alzheimer’s disease (Kaphzan et al., 2011; Sun et al., 2014).
However, our understanding of AIS composition, development
and regulation is still limited. Which are the extrinsic and
intrinsic mechanisms that modulate the AIS? The AIS has
been proven to respond to external stimuli with a high
degree of structural plasticity. However, our knowledge of
the receptors, neurotransmitters and extracellular factors that
modulate AIS remains limited. Understanding how the AIS
can be deregulated may contribute to control and recover
physiological neuronal function.
Prior studies demonstrated that the purinergic receptor
P2X7 modulates AIS composition under pathological conditions
(Del Puerto et al., 2015). Due to its relation with the
P2Y1 receptor, the objective of our study was to decipher
whether the purinergic receptor P2Y1 plays a role in AIS
development andmaintenance. Our results show that ADP-P2Y1
receptor contributes to the initial accumulation of ankyrinG
at the AIS. P2Y1 suppression or inhibition decreases ankyrinG
levels, as well as, voltage-gated sodium channels, βIV-spectrin
and pMLC. P2Y1 is necessary for a proper elongation of the
axon in early stages and is expressed in dendrites and axon
terminals in cultured hippocampal neurons (del Puerto et al.,
2012). P2Y1 expression is not detected in AIS, as previously
mentioned for P2X7 (Del Puerto et al., 2015). Previous studies
demonstrated a correlation between dendrites length or caliber
and AIS properties (Hamada et al., 2016; Tapia et al., 2017).
Our results show that, in control neurons, dendrites length
and ankyrinG density is correlated, albeit there is no statistical
correlation between both parameters after P2Y1 suppression.
This suggests that P2Y1-mediated ankyrinG density regulation
entails additional mechanisms triggered by P2Y1 alone or in
coordination with other receptors. In fact, ankyrinG levels can
be recovered through ATP-P2X7 receptor inhibition in neurons
lacking P2Y1 receptor. A previous study demonstrated that
high extracellular concentrations of ATP decrease ankyrinG
density through P2X7 and calpain activation in mature cultured
hippocampal neurons (Del Puerto et al., 2015). Here, we show
that extracellular ADP or P2Y1 inhibition do not modify
ankyrinG density in these mature neurons. However, through
P2Y1 receptor, ADP is necessary to maintain ankyrinG density
in young cultured hippocampal neurons. The P2Y1 regulation
coincides with the initial stages of AIS development, between
4 and 10 DIV, when the diffusion barrier is being generated
(Brachet et al., 2010) and is lost once the AIS achieve a
certain degree of maturity and stability, around 10–14 DIV. In
fact, P2Y1 suppression or ADP treatment after 7 DIV has no
effect on ankyrinG density, while P2Y1 inactivation at 7 DIV
or before decreases ankyrinG density. As happened during
early axonal elongation (del Puerto et al., 2012), BBG-mediated
P2X7 inhibition reverts the effects of P2Y1 suppression on
ankyrinG density. However, P2X7 inhibition mediated recovery
was not as high as previously observed in mature neurons
(Del Puerto et al., 2015), suggesting that P2Y1 receptors
decrease their expression or function during AIS development,
while the importance of P2X7 increases. This recovery can
be the result of decreased P2X7-mediated calcium entry and
reduced calpain activation, but other mechanisms may also
participate in this regulation. P2Y1 and P2X7 receptors are
important regulators of neuronal excitability. P2Y1 receptors
are expressed postsynaptically on dendrites of pyramidal cells
and presynaptic terminals and participate in the regulation
of neuronal plasticity (Baran´ska et al., 2017). Interestingly,
P2X7 and P2Y1 are balanced over the regulation of cAMP
and PKA activity, where P2Y1 contributes to increased cAMP
levels (del Puerto et al., 2012). It was postulated that a PKA
and phosphatases PP1 and calcineurin loop may regulate
sodium channels phosphorylation modulating spike firing that
correlates with AIS length in dentate granule cells (DGCs).
In this study (Evans et al., 2015), PKA activation did
not modify AIS length but did reverse the depolarization-
induced changes in sodium channels properties, increasing
their phosphorylation and decreasing conductance. Our results
show P2Y1 inhibition or suppression does not alter AIS
length, but rather proximally shifts the maximum ankyrinG
intensity while decreasing ankyrinG density. It remains to be
determined whether this shift is due to PKA activity levels or
modifications of sodium channels conductance. Nevertheless,
our results show that PP1/PP2A inhibition with calyculin A
is able to counteract the lack of P2Y1 expression, which
may balance PKA-phosphatases loop. On the other hand,
P2Y1 may participate in AIS modulation through regulation
of its actin cytoskeleton. In support, P2Y1 regulates Rac and
actin cytoskeleton in other cell types (Soulet et al., 2005). We
show that F-actin distribution and intensity in AIS is modified
after P2Y1 suppression, and actin cytoskeleton stabilization with
jasplakinolide recovers ankyrinG density. In fact, short-time
treatment with potassium chloride decreases ankyrinG density
at the AIS while at the same time actin is destabilized (Berger
et al., 2018). This may be caused by decreased phosphorylation
of myosin II light chain ( pMLC) at the AIS (Berger et al.,
2018). Our results demonstrate that P2Y1 suppression decreases
pMLC levels at the AIS at the same time that ankyrinG density
is reduced in a similar percentage. The lack of P2Y1 receptor
is compensated by inhibition of MLC phosphatase using
calyculin A. Interestingly, P2Y1 agonist, 2MeSADP, increases
pMLC phosphorylation in platelets generating a shape change
(Getz et al., 2010), through a Gq dependent mechanism.
All these data suggest that P2Y1 receptor participate in the
global regulation of AIS cytoskeleton dynamics during its
initial development.
CONCLUSION
In conclusion, our work demonstrates that P2Y1 receptor
participates only during initial AIS development. This may
represent decreased expression or function during neuronal
maturation, while other receptors, such as P2X7, increase
their participation and function in more mature neurons.
P2Y1 expression levels or functional activation/deactivation
in coordination with other receptors and mechanisms may
participate in the fine modulation of AIS development. Future
work will be necessary to completely understand the molecular
mechanisms underlying P2Y1 receptor; both at the level of
plasticity and the modulation of AIS cytoskeleton.
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